Exchange: NASDAQ·Updated 04:00 PM EDT

LTGO Latigo Biotherapeutics Inc.

$23.93
$0.87
(3.77%)
Today
EarningsNov 12
Mkt Cap$1.53B
Vol431,029.00

About LTGO

Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded by Bryan Moyer on November 20, 2018 and is headquartered in Thousand Oaks, CA.
39

Bearish Sentiment

How do you feel about LTGO?

Advertisement|Remove ads.